Filtered By:
Management: Funding
This page shows you your search results in order of date.
Order by Relevance | Date
Total 17 results found since Jan 2013.
Tuning in to Your Most-Ignored Sense Can Make You Happier
Somewhere along the long, winding road of evolution, a bunch of genes got together in a conference room and decided it would probably be most optimal for human survival if we were forced to take in every sound all around us at all times. Thus, the ear was born. Unlike their neighbors the eyes, the ears came with no on/off option. This is a great safety feature if you’re living in a cave surrounded by predators, but it’s since been hijacked by a world in which you’re more likely to find yourself trying to sleep through a neighbor’s car alarm blaring at 1 A.M.
[time-brightcove not-tgx=”trueR...
Source: TIME: Health - January 6, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Mental Health Wellbeing Source Type: news
The effects of radiofrequency electromagnetic fields exposure on tinnitus, migraine and non-specific symptoms in the general and working population: A protocol for a systematic review on human observational studies
Environ Int. 2021 Sep 6;157:106852. doi: 10.1016/j.envint.2021.106852. Online ahead of print.ABSTRACTBACKGROUND: Applications emitting radiofrequency electromagnetic fields (RF-EMF; 100 kHz to 300 GHz) are widely used for communication (e.g. mobile phones), in medicine (diathermy) and in industry (RF heaters). Concern has been raised that RF-EMF exposure affects health related quality of life, because a part of the population reports to experience a variety of symptoms related to low exposure levels below regulatory limits.OBJECTIVES: To systematically review the effects of longer-term or repeated local and whole human bod...
Source: Environment International - September 9, 2021 Category: Environmental Health Authors: Martin R öösli Stefan Dongus Hamed Jalilian Maria Feychting John Eyers Ekpereonne Esu Chioma Moses Oringanje Martin Meremikwu Xavier Bosch-Capblanch Source Type: research
Effectiveness of endolymphatic duct blockage versus endolymphatic sac decompression in patients with intractable Menieres disease: study protocol for a double-blinded, randomised controlled trial
This study was reviewed and approved by a board of specialists before funding was obtained, as well as by the Medical Research Ethics Committee Leiden-The Hague-Delft and the boards of all participating centres. Results of this study will be published in international peer-reviewed scientific journals and will be presented on (inter)national scientific conferences and meetings.
Trial registration numbers
NL9095 and ISRCTN12074571; Pre-Results.
Source: BMJ Open - August 10, 2021 Category: General Medicine Authors: Schenck, A. A., Kruyt, J. M., van Benthem, P. P., Cannegieter, S. C., van den Hout, W. B., Böhringer, S., Hammer, S., Hombergen, S. P. M., Blom, H. M. Tags: Open access, Ear, nose and throat/otolaryngology Source Type: research
Advancing tinnitus research and researcher training: A case study review and future perspectives
Prog Brain Res. 2021;263:191-208. doi: 10.1016/bs.pbr.2021.04.007. Epub 2021 May 20.ABSTRACTTinnitus affects one in 10 people and for many significantly impairs quality of life. Whilst there has been a notable increase in tinnitus research funding and tinnitus-related scientific publications in recent years, this is not keeping pace with other disciplines such as hearing loss. Tinnitus research is less attractive to industry funders, in particular because the field lacks consensus on many topics, objective measures, and treatment success stories. There is a clear need for even more funding, better quality studies, increase...
Source: Brain Research - July 10, 2021 Category: Neurology Authors: Dawn Hazle Axel Schiller Derek J Hoare Winfried Schlee Source Type: research
Towards a unification of treatments and interventions for tinnitus patients: The EU research and innovation action UNITI
Prog Brain Res. 2021;260:441-451. doi: 10.1016/bs.pbr.2020.12.005. Epub 2021 Feb 4.ABSTRACTTinnitus is the perception of a phantom sound and the patient's reaction to it. Although much progress has been made, tinnitus remains a scientific and clinical enigma of high prevalence and high economic burden, with an estimated prevalence of 10%-20% among the adult population. The EU is funding a new collaborative project entitled "Unification of Treatments and Interventions for Tinnitus Patients" (UNITI, grant no. 848261) under its Horizon 2020 framework. The main goal of the UNITI project is to set the ground for a predictive co...
Source: Brain Research - February 27, 2021 Category: Neurology Authors: Winfried Schlee Stefan Schoisswohl Susanne Staudinger Axel Schiller Astrid Lehner Berthold Langguth Martin Schecklmann Jorge Simoes Patrick Neff Steven C Marcrum Myra Spiliopoulou Uli Niemann Miro Schleicher Vishnu Unnikrishnan Clara Puga Lena Mulansky Ru Source Type: research
Role of the Department of Defense Hearing Center of Excellence in Studying the Treatment of Tinnitus
Against poor odds, Formby and colleagues managed to receive federal grant funding for a multisite clinical trial, to access and convince military investigators to join in this trial, to select rigorous measures and methods when no objective tinnitus measurement exists, and to gain approvals from all levels of regulatory and local command authority oversight bodies across 6 military treatment facilities before they could start their effort to complete the Tinnitus Retraining Therapy Trial (TRTT), described by Scherer and Formby in this issue ofJAMA Otolaryngology –Head& Neck Surgery. In just shy of 20 years from the t...
Source: JAMA Otolaryngology - Head and Neck Surgery - May 23, 2019 Category: ENT & OMF Source Type: research
New Device Helps People Suffering From Ringing In Ears
BOSTON (CBS) – It is estimated that 1 in 5 people suffer from tinnitus, a ringing or buzzing in the ear, that can be so intrusive it can affect a person’s quality of life.
Now researchers at the University of Michigan say a new experimental device that targets unruly nerve cells in the brain can help quiet the “phantom sounds” of tinnitus.
Human study participants who used the device daily said the loudness of the sounds was reduced and their quality of life improved.
Some people have tinnitus so bad they can’t do their jobs and can’t function at home, and current treatments include using sound ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 10, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Syndicated Local Dr. Mallika Marshall Local TV Tinnitus Source Type: news
Google backs Decibel Therapeutics in big data hearing loss play
Decibel Therapeutics said today it landed an investment from GV, formerly Google Ventures.
GV agreed to make an equity investment in the Boston-based company and lend its capabilities in big data sciences and analytics to Decibel’s efforts in developing therapies for hearing loss and tinnitus.
Get the full story at our sister site, Drug Delivery Business News.
The post Google backs Decibel Therapeutics in big data hearing loss play appeared first on MassDevice.
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Big Data Drug-Device Combinations Funding Roundup Otolaryngology Ear, Nose & Throat Pharmaceuticals Research & Development Wall Street Beat decibeltherapeutics google Source Type: news
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial
Publication date: Available online 12 January 2017 Source:The Lancet Haematology Author(s): Preetesh Jain, Michael Keating, Sarah Renner, Charles Cleeland, Huang Xuelin, Graciela Nogueras Gonzalez, David Harris, Ping Li, Zhiming Liu, Ivo Veletic, Uri Rozovski, Nitin Jain, Phillip Thompson, Prithviraj Bose, Courtney DiNardo, Alessandra Ferrajoli, Susan O'Brien, Jan Burger, William Wierda, Srdan Verstovsek, Hagop Kantarjian, Zeev Estrov Background Disease-related symptoms impair the quality of life of patients with chronic lymphocytic leukaemia (CLL) who do not require systemic therapy. Available therapies are not specifica...
Source: The Lancet Haematology - January 11, 2017 Category: Hematology Source Type: research
One Fund Boston to distribute an additional $19 million to Marathon bombing survivors
One Fund Boston today announced it would distribute an additional nearly $19 million and also released the protocol by which it would use to determine who should get the funding.
The funding will be distributed as cash gifts to those who have been most affected by last year's Marathon bombings, the One Fund said in a statement. Money also will be provided to fund a medical collaborative that will care for hidden wounds from the bombings, including tinnitus, hearing loss, mental health, PTSD and…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 14, 2014 Category: Pharmaceuticals Authors: Mary Moore Source Type: research
MicroTransponder completes $3.4M in funding, gets key patent
Dallas-based MicroTransponder Inc., a privately-held medical device company, has completed a $3.39 million funding round this summer, which will enable the company to accelerate development of its wireless pain platform.
The funding will allow MicroTransponder to complete three additional clinical trials using its neurostimulation system to treat both stroke patients and tinnitus patients, Jordan Curnes, co-founder, president and chief operating officer, told me.
Tinnitus is the medical term for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2013 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: research
